Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
WSTWest Pharmaceutical Services
FinDog View：Neutral
| Metric | JNJ | WST |
|---|
| Close | 267.28 | 362.01 |
| Market Cap | $644B | $23.9B |
| 1M | +1.87% | +4.44% |
| P/E (TTM) | 30.6 | 43.1 |
| Forward P/E | 20.7 | 36.0 |
| P/E 5-Yr Percentile | 90 | 49 |
| P/S | 6.6 | 7.3 |
| P/B | 7.6 | 8.2 |
| Dividend Yield | 3.12% | 0.33% |
| Latest Quarter Revenue | $25.3B | $872M |
| Revenue YoY | +6.6% | +13.8% |
| Gross Margin | 68.2% | 37.7% |
| Latest Quarter EPS | 2.27 | 2.15 |
| Avg Post-Earnings Move | ±0.6% | ±3.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 1 / 1 |
| Shareholder Yield | 1.25% | 2.16% |
| 90-Day Net Insider Buying | −$67.8M | −$5.4M |
JNJ · Revenue, Last 8 Quarters ($B)
WST · Revenue, Last 8 Quarters ($B)
